Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axcella Health Inc. (AXLA) since 2019 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Axcella Health Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1633070.
Total stock buying since 2019: $62,303,303.
Total stock sales since 2019: $164,233.
Total stock option exercises since 2019: $22,801.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 0 | $0 | 5,900 | $3,838 | 0 | $0 |
| 2022 | 13,208,273 | $24,239,992 | 35,374 | $58,763 | 54,604 | $0 |
| 2021 | 0 | $0 | 18,472 | $101,632 | 153,710 | $22,801 |
| 2020 | 5,806,312 | $27,564,704 | 0 | $0 | 0 | $0 |
| 2019 | 583,308 | $10,498,607 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-03 | 0 | $0 | 679 | $393 | 0 | $0 |
| 2023-02 | 0 | $0 | 5,221 | $3,445 | 0 | $0 |
| 2022-10 | 3,658,536 | $5,999,999 | 16,000 | $25,024 | 0 | $0 |
| 2022-09 | 0 | $0 | 1,641 | $4,134 | 0 | $0 |
| 2022-06 | 0 | $0 | 590 | $1,186 | 0 | $0 |
| 2022-03 | 9,549,737 | $18,239,993 | 553 | $1,029 | 1,535 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 1,534 | $0 |
| 2022-01 | 0 | $0 | 16,590 | $27,390 | 51,535 | $0 |
| 2021-12 | 0 | $0 | 0 | $0 | 1,535 | $0 |
| 2021-11 | 0 | $0 | 0 | $0 | 1,534 | $0 |
| 2021-10 | 0 | $0 | 0 | $0 | 1,535 | $0 |
| 2021-09 | 0 | $0 | 0 | $0 | 1,535 | $0 |
| 2021-08 | 0 | $0 | 0 | $0 | 82,967 | $22,801 |
| 2021-07 | 0 | $0 | 0 | $0 | 1,535 | $0 |
| 2021-05 | 0 | $0 | 0 | $0 | 1,534 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 1,535 | $0 |
| 2021-02 | 0 | $0 | 18,472 | $101,632 | 60,000 | $0 |
| 2020-05 | 5,786,842 | $27,487,499 | 0 | $0 | 0 | $0 |
| 2020-02 | 14,805 | $54,238 | 0 | $0 | 0 | $0 |
| 2020-01 | 4,665 | $22,967 | 0 | $0 | 0 | $0 |
| 2019-11 | 45,015 | $160,887 | 0 | $0 | 0 | $0 |
| 2019-08 | 6,941 | $48,618 | 0 | $0 | 0 | $0 |
| 2019-07 | 11,352 | $95,207 | 0 | $0 | 0 | $0 |
| 2019-06 | 20,000 | $193,895 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-01 | Koziel Margaret (Chief Medical Officer) | Sale | 679 | .58 | 393 |
| 2023-02-10 | Fehlner Paul (SVP & Chief Legal Officer) | Sale | 5,221 | .66 | 3,445 |
| 2022-10-19 | Hinshaw William (President & CEO) | Sale | 16,000 | 1.56 | 25,024 |
| 2022-10-13 | Nestle Sa (10% Owner) | Buy | 3,658,536 | 1.64 | 5,999,999 |
| 2022-09-06 | Koziel Margaret (Chief Medical Officer) | Sale | 1,094 | 2.52 | 2,756 |
| 2022-06-01 | Koziel Margaret (Chief Medical Officer) | Sale | 590 | 2.01 | 1,186 |
| 2022-03-18 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2022-03-16 | Fehlner Paul (SVP & Chief Legal Officer) | Buy | 10,471 | 1.91 | 19,999 |
| 2022-03-16 | Hinshaw William (President & CEO) | Buy | 13,089 | 1.91 | 24,999 |
| 2022-03-16 | Epstein David R | Buy | 26,178 | 1.91 | 49,999 |
| 2022-03-16 | Crane Robert (Chief Financial Officer) | Buy | 39,267 | 1.91 | 74,999 |
| 2022-03-16 | Afeyan Noubar (10% Owner) | Buy | 6,319,371 | 1.91 | 12,069,998 |
| 2022-03-16 | Nestle Sa (10% Owner) | Buy | 3,141,361 | 1.91 | 5,999,999 |
| 2022-03-01 | Koziel Margaret (Chief Medical Officer) | Sale | 553 | 1.86 | 1,029 |
| 2022-02-18 | Epstein David R | Option Ex | 1,534 | .00 | 0 |
| 2022-01-31 | Hinshaw William (President and CEO) | Sale | 16,590 | 1.65 | 27,390 |
| 2022-01-28 | Hinshaw William (President and CEO) | Option Ex | 50,000 | .00 | 0 |
| 2022-01-18 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2021-12-17 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2021-11-18 | Epstein David R | Option Ex | 1,534 | .00 | 0 |
| 2021-10-18 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2021-09-17 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2021-08-18 | Epstein David R | Option Ex | 1,534 | .00 | 0 |
| 2021-08-13 | Pisano Gary P. | Option Ex | 81,433 | .28 | 22,801 |
| 2021-07-16 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2021-05-18 | Epstein David R | Option Ex | 1,534 | .00 | 0 |
| 2021-04-18 | Epstein David R | Option Ex | 1,535 | .00 | 0 |
| 2021-02-01 | Chakravarthy Manu (SVP & Chief Medical Officer) | Sale | 18,472 | 5.50 | 101,632 |
| 2021-02-01 | Chakravarthy Manu (SVP & Chief Medical Officer) | Option Ex | 60,000 | .00 | 0 |
| 2020-05-18 | Nestle Us Holdco, Inc. (10% Owner) | Buy | 1,936,842 | 4.75 | 9,199,999 |
| 2020-05-18 | Epstein David R (Director) | Buy | 50,000 | 4.75 | 237,500 |
| 2020-05-18 | Afeyan Noubar (10% Owner) | Buy | 3,800,000 | 4.75 | 18,050,000 |
| 2020-02-28 | Epstein David R (Director) | Buy | 2,005 | 3.75 | 7,518 |
| 2020-02-27 | Epstein David R (Director) | Buy | 12,800 | 3.65 | 46,720 |
| 2020-01-31 | Chardonnet Laurent (Chief Financial Officer) | Buy | 3,000 | 4.94 | 14,820 |
| 2020-01-27 | Chardonnet Laurent (Chief Financial Officer) | Buy | 352 | 4.94 | 1,738 |
| 2020-01-24 | Chardonnet Laurent (Chief Financial Officer) | Buy | 313 | 4.92 | 1,539 |
| 2020-01-17 | Sohn Catherine A. | Buy | 1,000 | 4.87 | 4,870 |
| 2019-11-27 | Epstein David R (Director) | Buy | 2,010 | 3.91 | 7,858 |
| 2019-11-26 | Epstein David R (Director) | Buy | 28,000 | 3.55 | 99,400 |
| 2019-08-02 | Epstein David R (Director) | Buy | 2,849 | 7.04 | 20,056 |
| 2019-08-01 | Epstein David R (Director) | Buy | 4,092 | 6.98 | 28,562 |
| 2019-07-17 | Epstein David R (Director) | Buy | 1,000 | 7.55 | 7,550 |
| 2019-07-10 | Epstein David R (Director) | Buy | 1,322 | 8.07 | 10,668 |
| 2019-07-09 | Epstein David R (Director) | Buy | 4,200 | 8.24 | 34,608 |
| 2019-07-08 | Epstein David R (Director) | Buy | 274 | 9.00 | 2,466 |
| 2019-07-03 | Epstein David R (Director) | Buy | 56 | 8.99 | 503 |
| 2019-07-02 | Epstein David R (Director) | Buy | 3,500 | 8.77 | 30,677 |
| 2019-07-01 | Epstein David R (Director) | Buy | 1,000 | 8.73 | 8,735 |
| 2019-06-28 | Epstein David R (Director) | Buy | 5,400 | 10.04 | 54,215 |
| 2019-06-27 | Epstein David R (Director) | Buy | 100 | 9.15 | 915 |
| 2019-06-26 | Epstein David R (Director) | Buy | 14,500 | 9.57 | 138,765 |
| 2019-05-13 | Kania Edwin M Jr (10% Owner) | Buy | 500,000 | 20.00 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AXLA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Axcella Health Inc. (symbol AXLA, CIK number 1633070) see the Securities and Exchange Commission (SEC) website.